Neuroscience Institute, National Research Council (CNR), Pisa, Italy; NEUROFARBA, University of Florence, Florence, Italy.
Neuroscience Institute, National Research Council (CNR), Pisa, Italy.
Neuropharmacology. 2019 Feb;145(Pt A):114-122. doi: 10.1016/j.neuropharm.2018.02.006. Epub 2018 Feb 8.
Amblyopia is the most common cause of visual impairment in one eye, with a prevalence of 1-5% in the world population. While amblyopia can be efficiently treated in children, it becomes irreversible in adults, due to the decline in neural plasticity past the end of the visual cortex critical period. Accordingly, no pharmacological approaches are available to rescue visual functions in adult amblyopic subjects. We report that non-invasive intranasal infusion of BDNF increased levels of this neurotrophic factor in V1 and induced a recovery of visual acuity, ocular dominance and visual depth perception in adult amblyopic rats, both in reverse-occluded animals and in those with unrestricted binocular sight. Visual recovery was long-lasting, and was prevented by pharmacological blockade of TrkB signaling in the visual cortex. These results underscore the possibility to replace invasive BDNF central administration with a safe procedure of potential interest in a number of currently still cureless central nervous system pathologies. This article is part of the Special Issue entitled "Neurobiology of Environmental Enrichment".
弱视是单眼视力障碍最常见的原因,在世界人口中的发病率为 1-5%。虽然弱视在儿童中可以得到有效治疗,但由于视觉皮层关键期结束后神经可塑性下降,成年人的弱视则变得不可逆转。因此,对于成年弱视患者,尚无药物方法可用于挽救其视觉功能。我们报告称,非侵入性的经鼻内 BDNF 输注可增加 V1 中这种神经营养因子的水平,并在成年弱视大鼠中诱导视力、眼优势和视觉深度知觉的恢复,无论是在反向遮盖的动物还是在双眼不受限制的动物中都是如此。视觉恢复是持久的,并且可以通过在视觉皮层中阻断 TrkB 信号转导来预防。这些结果强调了用一种安全的程序替代有创的 BDNF 中枢给药的可能性,这种程序可能对目前仍无法治愈的许多中枢神经系统疾病具有潜在的重要意义。本文是题为“环境富集的神经生物学”的特刊的一部分。